Adventris Pharmaceuticals
Adventris makes cancer vaccines
Founders
Not read from YC yet; the weekly run fills these in.
Same space
Competitors
Closest in what they build, same category.
AlixiaW22Targeting the Tumor Ecosystem to address cancer drug resistance.Shared: biotech, therapeutics, drug discoveryActive
Velorum TherapeuticsW24Breakthrough medicines unlocking the biology of hemeShared: biotech, healthcare, therapeuticsActive
Eris BiotechW24Our drugs engage the immune system to fight tumorsShared: biotech, therapeutics, drug discoveryActive
Notable LabsW15Personalized drug discovery for blood cancer.Shared: biotech, drug discovery, oncologyPublic
Pardes BiosciencesS20We break virusesShared: biotech, therapeuticsPublic
Adjacent
Overlapping tags, a different niche.
Guardian BioS22Dendritic cell-based platform for cancer therapyShared: biotech, healthcare, therapeuticsActive
Granza BioW24Building programmable therapeutics for the immune systemShared: biotech, healthcare, therapeuticsActive
Engage BioW22Potent, durable, and redosable non-viral genetic medicinesShared: biotech, healthcare, therapeuticsAcquired
Algen BiotechnologiesW20Using CRISPR to find treatments for cancer and inflammationShared: biotech, therapeutics, drug discoveryActive
Numerion LabsW15Artificial intelligence for drug discovery.Shared: biotech, drug discovery, oncologyActive
Also from W23
Batchmates in Winter 2023.
Lavo Life SciencesW23AI for drug formulationInactive
CombineHealthW23Automating Healthcare Revenue Cycle Management with AI WorkforceActive
Diffuse BioW23Generative AI for protein designActive
Fairway HealthW23AI Co-Pilot for Health Insurers to Authorize Treatment FasterAcquired
Glass HealthW23AI-Powered Clinical Decision Support & Ambient ScribingActive
Hippo ScribeW23AI assisted documentation for PT/OT/SLPActive
About Adventris Pharmaceuticals
Adventris makes cancer vaccines. Our platform solves the problem of targeting poorly immunogenic oncogenes. Our first "off-the-shelf" vaccine targets KRAS, the most common cancer oncogene. In the long run, we envision a world where every adult receives our pan-cancer vaccines annually – preventing the majority of cancer deaths. If you are interested in learning more about our approach to treat and prevent cancer, please reach out to us at contact@adventris.com
Baltimore, MD, USA
Adventris Pharmaceuticals: questions
Which YC batch was Adventris Pharmaceuticals in?
Adventris Pharmaceuticals was in Y Combinator's Winter 2023 batch (W23).
Is Adventris Pharmaceuticals still active?
Y Combinator lists Adventris Pharmaceuticals as active.
Where is Adventris Pharmaceuticals based?
Adventris Pharmaceuticals lists Baltimore, MD, USA as its location on YC's directory.
Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.